Additional Helpful Links
Watch our webinar with the U.S. Department of Health and Human Services (HHS), "Increasing Access and Utilization of COVID-19 mAbs at Infusion Centers"
The National Infusion Center Association (NICA) has been working closely with pharmaceutical manufacturers and governmental partners at The Operation to ensure healthcare providers have the resources needed to safely and appropriately prescribe and administer these COVID-19 antibody therapies.
Disclaimer: NICA developed these materials to help promote safe, efficient, and responsible use of COVID-19 infusion therapies. We encourage you to print, copy, distribute, transmit and otherwise use these materials; however, we ask that you credit NICA and/or the Infusion Access Foundation (IAF) appropriately. If materials/content are modified in any way, the NICA logo must be removed and attribution for content given as follows: “Adapted from materials developed by the National Infusion Center Association” (or Infusion Access Foundation, as appropriate).
These resources are intended for reference only and do not replace proper training and competency validation.